Home » Topics » Regulatory

Regulatory
RSS

Casodex 150 mg not recommended for use in U.S. in early prostate cancer

Jan. 2, 2003

E.U. approval obtained for once-weekly Actonel/Optinate for postmenopausal osteoporosis

Jan. 2, 2003

Once-daily Depakote ER approved for certain forms of epilepsy

Jan. 2, 2003

FDA approval for Xalatan as first-line therapy for elevated IOP

Jan. 2, 2003

Shire seeks approval of Adderall XR in adults

Dec. 23, 2002

Kytril available in oral solution for CINV and RINV

Dec. 23, 2002

Moxifloxacin NDA filed for bacterial conjunctivitis and ophthalmia neonatorum

Dec. 20, 2002

E.U. approval obtained for use of Enbrel in psoriatic arthritis

Dec. 20, 2002

Lantus: E.U. approval for flexible use, positive opinion for pediatric use

Dec. 19, 2002

Approvable letter for Advair Diskus

Dec. 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...